BNTX
BioNTech SENASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$22.94B
P/E Ratio
—
EPS
$-5.44
Beta
1.59
52W High
$124.00
52W Low
$79.52
50-Day MA
$101.49
200-Day MA
$103.37
Dividend Yield
—
Profit Margin
-39.60%
Forward P/E
7.04
PEG Ratio
0.05
About BioNTech SE
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Fundamentals
| Revenue (TTM) | $2.87B |
| Gross Profit (TTM) | $2.26B |
| EBITDA | $-1.12B |
| Operating Margin | -33.40% |
| Return on Equity | -5.88% |
| Return on Assets | -3.56% |
| Revenue/Share (TTM) | $11.87 |
| Book Value | $88.53 |
| Price-to-Book | 1.03 |
| Price-to-Sales (TTM) | 7.99 |
| EV/Revenue | 1.799 |
| EV/EBITDA | 32.70 |
| Quarterly Earnings Growth (YoY) | -43.20% |
| Quarterly Revenue Growth (YoY) | -23.70% |
| Shares Outstanding | $251.32M |
| Float | $96.55M |
| % Insiders | 57.42% |
| % Institutions | 20.58% |
Analyst Ratings
Consensus ($131.13 target)
1
Strong Buy14
Buy5
HoldData last updated: 4/7/2026